Home
About
Overview
Sharing Data
ORCID
Help
History (36)
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out.
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumors.
Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal.
See All 36 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal.
Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal. J Clin Oncol. 2023 09 01; 41(25):4093-4096.
View in:
PubMed
subject areas
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Circulating Tumor DNA
Humans
Lung Neoplasms
authors with profiles
Marina Chiara Garassino
Everett Vokes
Christine Bestvina